Digital Health-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2184948, encodeId=f4f92184948cf, content=审稿速度:1.0 | 影响因子:3.9 偏重的研究方向：移动健康 经验分享：23.09.23 Awaiting Admin Processing 09.25 Awaiting AE Assignment 09.27 Awaiting Reviewers Selection 09.28 Awaiting Reviewers Assignment 10.9 Awaiting Reviewers Selection 10.11 Awaiting Reviewers Invitation 10.11 Awaiting Reviewers Assignment 10.12 Awaiting Reviewer Scores 10.25 Awaiting AE Recommendation 10.30 Awaiting Decision 11.7 Major Revision 11.19 修回 11.19 Awaiting Admin Processing 11.20 Awaiting Reviewers Selection 11.21 Awaiting Reviewers Assignment 11.22 Awaiting Reviewer Scores 11.27 Awaiting AE Recommendation 11.30 Awaiting Decision 11.30 Major Revision 12.29 修回 12.29 Awaiting Admin Processing 12.30 Revision 24.01.12 Awaiting Reviewer Scores 01.26 Awaiting AE Recommendation 01.30 Awaiting Decision 01.30 Accept（Awaiting Production Checklist） Digital Health 投稿分享 1. 投稿后编辑处理迅速，4天后稿件送外审； 2. 该杂志审稿人比较难邀请，一审经历了两轮邀请后有两位审稿人审稿，审稿迅速共持续13天，可能由于涉及多学科，一审后的Awaiting AE Recommendation和Awaiting Decision一共持续了13天； 3. 12天后返修二审，二审较快持续5天，Awaiting AE Recommendation和Awaiting Decision也较快且编辑当天给出意见，又给了大修； 4. 因为个人原因，一直拖到1个月返修期限12.29才返修，可能正好赶上编辑部放假，一直显示Revision状态，直到13天后直接跳到审稿人审稿状态，然后又经历了13天审稿，接着4天后直接接收（It is a pleasure to accept your manuscript entitled "XXX" in its current form for publication in Digital Health.）。 5. 一审中审稿人2给了9个意见，非常详细，对文章修改和文章写作很有帮助。二审中审稿人1没有任何意见，审稿人2还有少许意见，一直强调我的研究还有缺点，意见比较刁钻，所以编辑又给了大修。第一次和第二次修回查阅了大量文献且每次回复都两三千字，三审中审稿人2终于表示满意。此外，杂志编辑也是很友好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Tue Jan 30 23:24:46 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203595, encodeId=8e2022035955a, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：移动健康 经验分享：2024.1月6号投稿：Awaiting Admin Processing 2024.1月7号：Submitted 2024.1.14 Awaiting Reviewer Selection 2024.1.26 Awaiting Reviewer Scores 2024.1.29 Awaiting AE Recommendation 2024.1.30 Awaiting Decision 2024.1.31 Major Revision 1.review1的意见很少 2.review2给了整整3页意见，特别细致（意见也比较针对） 修改了近一个月，再次提交： 2024-02-29 Awaiting Admin Processing 2024-03-02 Revision 2024-03-05 Awaiting Reviewer Invitation 2024-04-03 Returned by Admin 由于修改后忘了标记稿件修改的内容，白等了一个月，被编辑退回来了（期间发了邮件咨询为啥一直没动静） 2024-04-09 Awaiting Admin Processing 2024-04-10 Awaiting Reviewer Invitation 2024-04-12 Awaiting Reviewer Scores 2024-04-14 Awaiting AE Recommendation 2024-04-18 Awaiting Decision 2024-04-18 Major Revision 还是之前的审稿人： 1.review1基本没有意见 2.review2回复一审有2个意见没有修改满意 全部意见修改好，再次提交稿件，很快就中了： 2024-05-04 Awaiting Admin Processing 2024-05-06 Revision 2024-05-07 Awaiting Reviewer Selection 2024-05-08 Awaiting AE Recommendation 2024-05-08 Awaiting Decision 2024-05-08 Accept (Awaiting Production Checklist), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Thu May 09 08:46:21 CST 2024, time=2024-05-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2203572, encodeId=31f622035e234, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：23.06.30 submit 2024.1.17 major revision 2024.4.5 minor revision 2024.5.8 accept 没以前好中了，审稿也比之前慢了很多，投了将近一年才接收，中间催了好几次，但感觉作用不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a8588011, createdName=ms4000000276684931, createdTime=Thu May 09 00:41:20 CST 2024, time=2024-05-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2203430, encodeId=11eb22034308c, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：电子;健康 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ca8320823, createdName=ms9000001836297684, createdTime=Wed May 08 11:05:27 CST 2024, time=2024-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198712, encodeId=25f82198e124e, content=审稿速度:24.0 经验分享：审稿好慢。。。找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1076466407, createdName=ms9000001994529014, createdTime=Tue Apr 16 00:20:03 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196447, encodeId=57ee219644e77, content=偏重的研究方向：移动健康 经验分享：第一次投稿很快不到1月出结果：2024-1-31 Major Revision。2024-02-29 修改提交后显示 Awaiting Admin Processing，2024-03-02 Revision，2024-03-05 Awaiting Reviewer Invitation。然后就没消息了，不知道为啥返修后一直邀请审稿人。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Mon Apr 01 14:24:48 CST 2024, time=2024-04-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194973, encodeId=62d421949e3d2, content=我是这本期刊的审稿人，半年内已邀请审稿5次，主要方向为移动健康，信不信由你们。 如果有什么需要咨询的可留言或私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c1f6417428, createdName=ms2000001410436675, createdTime=Sun Mar 24 10:59:35 CST 2024, time=2024-03-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2184823, encodeId=a1ab2184823dd, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：2023年6月底投稿 2024年1月底接收编辑和审稿人都很温柔祝大家顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be958186362, createdName=论文保安, createdTime=Tue Jan 30 13:57:22 CST 2024, time=2024-01-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184988, encodeId=a0df21849883d, content=11月21号投稿，12月份大修，修回后1月25号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Jan 31 09:09:55 CST 2024, time=2024-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184884, encodeId=fb962184884a3, content=偏重的研究方向：移动健康 经验分享：1月6号投稿：Awaiting Admin Processing。1月7号：Submitted。1.14 Awaiting Reviewer Selection. 1.26 Awaiting Reviewer Scores 1.29 Awaiting AE Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Tue Jan 30 19:49:10 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省)]

2024-01-30 ms5000001996918480 来自江苏省

审稿速度:1.0 | 影响因子:3.9
偏重的研究方向：移动健康
经验分享：23.09.23 Awaiting Admin Processing 09.25 Awaiting AE Assignment 09.27 Awaiting Reviewers Selection 09.28 Awaiting Reviewers Assignment 10.9 Awaiting Reviewers Selection 10.11 Awaiting Reviewers Invitation 10.11 Awaiting Reviewers Assignment 10.12 Awaiting Reviewer Scores 10.25 Awaiting AE Recommendation 10.30 Awaiting Decision 11.7 Major Revision 11.19 修回 11.19 Awaiting Admin Processing 11.20 Awaiting Reviewers Selection 11.21 Awaiting Reviewers Assignment 11.22 Awaiting Reviewer Scores 11.27 Awaiting AE Recommendation 11.30 Awaiting Decision 11.30 Major Revision 12.29 修回 12.29 Awaiting Admin Processing 12.30 Revision 24.01.12 Awaiting Reviewer Scores 01.26 Awaiting AE Recommendation 01.30 Awaiting Decision 01.30 Accept（Awaiting Production Checklist） Digital Health 投稿分享 1. 投稿后编辑处理迅速，4天后稿件送外审； 2. 该杂志审稿人比较难邀请，一审经历了两轮邀请后有两位审稿人审稿，审稿迅速共持续13天，可能由于涉及多学科，一审后的Awaiting AE Recommendation和Awaiting Decision一共持续了13天； 3. 12天后返修二审，二审较快持续5天，Awaiting AE Recommendation和Awaiting Decision也较快且编辑当天给出意见，又给了大修； 4. 因为个人原因，一直拖到1个月返修期限12.29才返修，可能正好赶上编辑部放假，一直显示Revision状态，直到13天后直接跳到审稿人审稿状态，然后又经历了13天审稿，接着4天后直接接收（It is a pleasure to accept your manuscript entitled "XXX" in its current form for publication in Digital Health.）。 5. 一审中审稿人2给了9个意见，非常详细，对文章修改和文章写作很有帮助。二审中审稿人1没有任何意见，审稿人2还有少许意见，一直强调我的研究还有缺点，意见比较刁钻，所以编辑又给了大修。第一次和第二次修回查阅了大量文献且每次回复都两三千字，三审中审稿人2终于表示满意。此外，杂志编辑也是很友好的。

56 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2184948, encodeId=f4f92184948cf, content=审稿速度:1.0 | 影响因子:3.9 偏重的研究方向：移动健康 经验分享：23.09.23 Awaiting Admin Processing 09.25 Awaiting AE Assignment 09.27 Awaiting Reviewers Selection 09.28 Awaiting Reviewers Assignment 10.9 Awaiting Reviewers Selection 10.11 Awaiting Reviewers Invitation 10.11 Awaiting Reviewers Assignment 10.12 Awaiting Reviewer Scores 10.25 Awaiting AE Recommendation 10.30 Awaiting Decision 11.7 Major Revision 11.19 修回 11.19 Awaiting Admin Processing 11.20 Awaiting Reviewers Selection 11.21 Awaiting Reviewers Assignment 11.22 Awaiting Reviewer Scores 11.27 Awaiting AE Recommendation 11.30 Awaiting Decision 11.30 Major Revision 12.29 修回 12.29 Awaiting Admin Processing 12.30 Revision 24.01.12 Awaiting Reviewer Scores 01.26 Awaiting AE Recommendation 01.30 Awaiting Decision 01.30 Accept（Awaiting Production Checklist） Digital Health 投稿分享 1. 投稿后编辑处理迅速，4天后稿件送外审； 2. 该杂志审稿人比较难邀请，一审经历了两轮邀请后有两位审稿人审稿，审稿迅速共持续13天，可能由于涉及多学科，一审后的Awaiting AE Recommendation和Awaiting Decision一共持续了13天； 3. 12天后返修二审，二审较快持续5天，Awaiting AE Recommendation和Awaiting Decision也较快且编辑当天给出意见，又给了大修； 4. 因为个人原因，一直拖到1个月返修期限12.29才返修，可能正好赶上编辑部放假，一直显示Revision状态，直到13天后直接跳到审稿人审稿状态，然后又经历了13天审稿，接着4天后直接接收（It is a pleasure to accept your manuscript entitled "XXX" in its current form for publication in Digital Health.）。 5. 一审中审稿人2给了9个意见，非常详细，对文章修改和文章写作很有帮助。二审中审稿人1没有任何意见，审稿人2还有少许意见，一直强调我的研究还有缺点，意见比较刁钻，所以编辑又给了大修。第一次和第二次修回查阅了大量文献且每次回复都两三千字，三审中审稿人2终于表示满意。此外，杂志编辑也是很友好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Tue Jan 30 23:24:46 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203595, encodeId=8e2022035955a, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：移动健康 经验分享：2024.1月6号投稿：Awaiting Admin Processing 2024.1月7号：Submitted 2024.1.14 Awaiting Reviewer Selection 2024.1.26 Awaiting Reviewer Scores 2024.1.29 Awaiting AE Recommendation 2024.1.30 Awaiting Decision 2024.1.31 Major Revision 1.review1的意见很少 2.review2给了整整3页意见，特别细致（意见也比较针对） 修改了近一个月，再次提交： 2024-02-29 Awaiting Admin Processing 2024-03-02 Revision 2024-03-05 Awaiting Reviewer Invitation 2024-04-03 Returned by Admin 由于修改后忘了标记稿件修改的内容，白等了一个月，被编辑退回来了（期间发了邮件咨询为啥一直没动静） 2024-04-09 Awaiting Admin Processing 2024-04-10 Awaiting Reviewer Invitation 2024-04-12 Awaiting Reviewer Scores 2024-04-14 Awaiting AE Recommendation 2024-04-18 Awaiting Decision 2024-04-18 Major Revision 还是之前的审稿人： 1.review1基本没有意见 2.review2回复一审有2个意见没有修改满意 全部意见修改好，再次提交稿件，很快就中了： 2024-05-04 Awaiting Admin Processing 2024-05-06 Revision 2024-05-07 Awaiting Reviewer Selection 2024-05-08 Awaiting AE Recommendation 2024-05-08 Awaiting Decision 2024-05-08 Accept (Awaiting Production Checklist), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Thu May 09 08:46:21 CST 2024, time=2024-05-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2203572, encodeId=31f622035e234, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：23.06.30 submit 2024.1.17 major revision 2024.4.5 minor revision 2024.5.8 accept 没以前好中了，审稿也比之前慢了很多，投了将近一年才接收，中间催了好几次，但感觉作用不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a8588011, createdName=ms4000000276684931, createdTime=Thu May 09 00:41:20 CST 2024, time=2024-05-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2203430, encodeId=11eb22034308c, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：电子;健康 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ca8320823, createdName=ms9000001836297684, createdTime=Wed May 08 11:05:27 CST 2024, time=2024-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198712, encodeId=25f82198e124e, content=审稿速度:24.0 经验分享：审稿好慢。。。找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1076466407, createdName=ms9000001994529014, createdTime=Tue Apr 16 00:20:03 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196447, encodeId=57ee219644e77, content=偏重的研究方向：移动健康 经验分享：第一次投稿很快不到1月出结果：2024-1-31 Major Revision。2024-02-29 修改提交后显示 Awaiting Admin Processing，2024-03-02 Revision，2024-03-05 Awaiting Reviewer Invitation。然后就没消息了，不知道为啥返修后一直邀请审稿人。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Mon Apr 01 14:24:48 CST 2024, time=2024-04-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194973, encodeId=62d421949e3d2, content=我是这本期刊的审稿人，半年内已邀请审稿5次，主要方向为移动健康，信不信由你们。 如果有什么需要咨询的可留言或私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c1f6417428, createdName=ms2000001410436675, createdTime=Sun Mar 24 10:59:35 CST 2024, time=2024-03-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2184823, encodeId=a1ab2184823dd, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：2023年6月底投稿 2024年1月底接收编辑和审稿人都很温柔祝大家顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be958186362, createdName=论文保安, createdTime=Tue Jan 30 13:57:22 CST 2024, time=2024-01-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184988, encodeId=a0df21849883d, content=11月21号投稿，12月份大修，修回后1月25号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Jan 31 09:09:55 CST 2024, time=2024-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184884, encodeId=fb962184884a3, content=偏重的研究方向：移动健康 经验分享：1月6号投稿：Awaiting Admin Processing。1月7号：Submitted。1.14 Awaiting Reviewer Selection. 1.26 Awaiting Reviewer Scores 1.29 Awaiting AE Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Tue Jan 30 19:49:10 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省)]

2024-05-09 ms3000001573572167 来自辽宁省

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：移动健康
经验分享：2024.1月6号投稿：Awaiting Admin Processing
2024.1月7号：Submitted
2024.1.14 Awaiting Reviewer Selection
2024.1.26 Awaiting Reviewer Scores
2024.1.29 Awaiting AE Recommendation
2024.1.30 Awaiting Decision
2024.1.31 Major Revision
1.review1的意见很少
2.review2给了整整3页意见，特别细致（意见也比较针对）
修改了近一个月，再次提交：

2024-02-29 Awaiting Admin Processing
2024-03-02 Revision
2024-03-05 Awaiting Reviewer Invitation
2024-04-03 Returned by Admin

由于修改后忘了标记稿件修改的内容，白等了一个月，被编辑退回来了（期间发了邮件咨询为啥一直没动静）

2024-04-09 Awaiting Admin Processing
2024-04-10 Awaiting Reviewer Invitation
2024-04-12 Awaiting Reviewer Scores
2024-04-14 Awaiting AE Recommendation
2024-04-18 Awaiting Decision
2024-04-18 Major Revision
还是之前的审稿人：
1.review1基本没有意见
2.review2回复一审有2个意见没有修改满意

全部意见修改好，再次提交稿件，很快就中了：
2024-05-04 Awaiting Admin Processing
2024-05-06 Revision
2024-05-07 Awaiting Reviewer Selection
2024-05-08 Awaiting AE Recommendation
2024-05-08 Awaiting Decision
2024-05-08 Accept (Awaiting Production Checklist)

136 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2184948, encodeId=f4f92184948cf, content=审稿速度:1.0 | 影响因子:3.9 偏重的研究方向：移动健康 经验分享：23.09.23 Awaiting Admin Processing 09.25 Awaiting AE Assignment 09.27 Awaiting Reviewers Selection 09.28 Awaiting Reviewers Assignment 10.9 Awaiting Reviewers Selection 10.11 Awaiting Reviewers Invitation 10.11 Awaiting Reviewers Assignment 10.12 Awaiting Reviewer Scores 10.25 Awaiting AE Recommendation 10.30 Awaiting Decision 11.7 Major Revision 11.19 修回 11.19 Awaiting Admin Processing 11.20 Awaiting Reviewers Selection 11.21 Awaiting Reviewers Assignment 11.22 Awaiting Reviewer Scores 11.27 Awaiting AE Recommendation 11.30 Awaiting Decision 11.30 Major Revision 12.29 修回 12.29 Awaiting Admin Processing 12.30 Revision 24.01.12 Awaiting Reviewer Scores 01.26 Awaiting AE Recommendation 01.30 Awaiting Decision 01.30 Accept（Awaiting Production Checklist） Digital Health 投稿分享 1. 投稿后编辑处理迅速，4天后稿件送外审； 2. 该杂志审稿人比较难邀请，一审经历了两轮邀请后有两位审稿人审稿，审稿迅速共持续13天，可能由于涉及多学科，一审后的Awaiting AE Recommendation和Awaiting Decision一共持续了13天； 3. 12天后返修二审，二审较快持续5天，Awaiting AE Recommendation和Awaiting Decision也较快且编辑当天给出意见，又给了大修； 4. 因为个人原因，一直拖到1个月返修期限12.29才返修，可能正好赶上编辑部放假，一直显示Revision状态，直到13天后直接跳到审稿人审稿状态，然后又经历了13天审稿，接着4天后直接接收（It is a pleasure to accept your manuscript entitled "XXX" in its current form for publication in Digital Health.）。 5. 一审中审稿人2给了9个意见，非常详细，对文章修改和文章写作很有帮助。二审中审稿人1没有任何意见，审稿人2还有少许意见，一直强调我的研究还有缺点，意见比较刁钻，所以编辑又给了大修。第一次和第二次修回查阅了大量文献且每次回复都两三千字，三审中审稿人2终于表示满意。此外，杂志编辑也是很友好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Tue Jan 30 23:24:46 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203595, encodeId=8e2022035955a, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：移动健康 经验分享：2024.1月6号投稿：Awaiting Admin Processing 2024.1月7号：Submitted 2024.1.14 Awaiting Reviewer Selection 2024.1.26 Awaiting Reviewer Scores 2024.1.29 Awaiting AE Recommendation 2024.1.30 Awaiting Decision 2024.1.31 Major Revision 1.review1的意见很少 2.review2给了整整3页意见，特别细致（意见也比较针对） 修改了近一个月，再次提交： 2024-02-29 Awaiting Admin Processing 2024-03-02 Revision 2024-03-05 Awaiting Reviewer Invitation 2024-04-03 Returned by Admin 由于修改后忘了标记稿件修改的内容，白等了一个月，被编辑退回来了（期间发了邮件咨询为啥一直没动静） 2024-04-09 Awaiting Admin Processing 2024-04-10 Awaiting Reviewer Invitation 2024-04-12 Awaiting Reviewer Scores 2024-04-14 Awaiting AE Recommendation 2024-04-18 Awaiting Decision 2024-04-18 Major Revision 还是之前的审稿人： 1.review1基本没有意见 2.review2回复一审有2个意见没有修改满意 全部意见修改好，再次提交稿件，很快就中了： 2024-05-04 Awaiting Admin Processing 2024-05-06 Revision 2024-05-07 Awaiting Reviewer Selection 2024-05-08 Awaiting AE Recommendation 2024-05-08 Awaiting Decision 2024-05-08 Accept (Awaiting Production Checklist), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Thu May 09 08:46:21 CST 2024, time=2024-05-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2203572, encodeId=31f622035e234, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：23.06.30 submit 2024.1.17 major revision 2024.4.5 minor revision 2024.5.8 accept 没以前好中了，审稿也比之前慢了很多，投了将近一年才接收，中间催了好几次，但感觉作用不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a8588011, createdName=ms4000000276684931, createdTime=Thu May 09 00:41:20 CST 2024, time=2024-05-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2203430, encodeId=11eb22034308c, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：电子;健康 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ca8320823, createdName=ms9000001836297684, createdTime=Wed May 08 11:05:27 CST 2024, time=2024-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198712, encodeId=25f82198e124e, content=审稿速度:24.0 经验分享：审稿好慢。。。找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1076466407, createdName=ms9000001994529014, createdTime=Tue Apr 16 00:20:03 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196447, encodeId=57ee219644e77, content=偏重的研究方向：移动健康 经验分享：第一次投稿很快不到1月出结果：2024-1-31 Major Revision。2024-02-29 修改提交后显示 Awaiting Admin Processing，2024-03-02 Revision，2024-03-05 Awaiting Reviewer Invitation。然后就没消息了，不知道为啥返修后一直邀请审稿人。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Mon Apr 01 14:24:48 CST 2024, time=2024-04-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194973, encodeId=62d421949e3d2, content=我是这本期刊的审稿人，半年内已邀请审稿5次，主要方向为移动健康，信不信由你们。 如果有什么需要咨询的可留言或私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c1f6417428, createdName=ms2000001410436675, createdTime=Sun Mar 24 10:59:35 CST 2024, time=2024-03-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2184823, encodeId=a1ab2184823dd, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：2023年6月底投稿 2024年1月底接收编辑和审稿人都很温柔祝大家顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be958186362, createdName=论文保安, createdTime=Tue Jan 30 13:57:22 CST 2024, time=2024-01-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184988, encodeId=a0df21849883d, content=11月21号投稿，12月份大修，修回后1月25号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Jan 31 09:09:55 CST 2024, time=2024-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184884, encodeId=fb962184884a3, content=偏重的研究方向：移动健康 经验分享：1月6号投稿：Awaiting Admin Processing。1月7号：Submitted。1.14 Awaiting Reviewer Selection. 1.26 Awaiting Reviewer Scores 1.29 Awaiting AE Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Tue Jan 30 19:49:10 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省)]

2024-05-09 ms4000000276684931 来自广东省

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：移动健康
经验分享：23.06.30 submit 2024.1.17 major revision 2024.4.5 minor revision 2024.5.8 accept 没以前好中了，审稿也比之前慢了很多，投了将近一年才接收，中间催了好几次，但感觉作用不大。

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2184948, encodeId=f4f92184948cf, content=审稿速度:1.0 | 影响因子:3.9 偏重的研究方向：移动健康 经验分享：23.09.23 Awaiting Admin Processing 09.25 Awaiting AE Assignment 09.27 Awaiting Reviewers Selection 09.28 Awaiting Reviewers Assignment 10.9 Awaiting Reviewers Selection 10.11 Awaiting Reviewers Invitation 10.11 Awaiting Reviewers Assignment 10.12 Awaiting Reviewer Scores 10.25 Awaiting AE Recommendation 10.30 Awaiting Decision 11.7 Major Revision 11.19 修回 11.19 Awaiting Admin Processing 11.20 Awaiting Reviewers Selection 11.21 Awaiting Reviewers Assignment 11.22 Awaiting Reviewer Scores 11.27 Awaiting AE Recommendation 11.30 Awaiting Decision 11.30 Major Revision 12.29 修回 12.29 Awaiting Admin Processing 12.30 Revision 24.01.12 Awaiting Reviewer Scores 01.26 Awaiting AE Recommendation 01.30 Awaiting Decision 01.30 Accept（Awaiting Production Checklist） Digital Health 投稿分享 1. 投稿后编辑处理迅速，4天后稿件送外审； 2. 该杂志审稿人比较难邀请，一审经历了两轮邀请后有两位审稿人审稿，审稿迅速共持续13天，可能由于涉及多学科，一审后的Awaiting AE Recommendation和Awaiting Decision一共持续了13天； 3. 12天后返修二审，二审较快持续5天，Awaiting AE Recommendation和Awaiting Decision也较快且编辑当天给出意见，又给了大修； 4. 因为个人原因，一直拖到1个月返修期限12.29才返修，可能正好赶上编辑部放假，一直显示Revision状态，直到13天后直接跳到审稿人审稿状态，然后又经历了13天审稿，接着4天后直接接收（It is a pleasure to accept your manuscript entitled "XXX" in its current form for publication in Digital Health.）。 5. 一审中审稿人2给了9个意见，非常详细，对文章修改和文章写作很有帮助。二审中审稿人1没有任何意见，审稿人2还有少许意见，一直强调我的研究还有缺点，意见比较刁钻，所以编辑又给了大修。第一次和第二次修回查阅了大量文献且每次回复都两三千字，三审中审稿人2终于表示满意。此外，杂志编辑也是很友好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Tue Jan 30 23:24:46 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203595, encodeId=8e2022035955a, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：移动健康 经验分享：2024.1月6号投稿：Awaiting Admin Processing 2024.1月7号：Submitted 2024.1.14 Awaiting Reviewer Selection 2024.1.26 Awaiting Reviewer Scores 2024.1.29 Awaiting AE Recommendation 2024.1.30 Awaiting Decision 2024.1.31 Major Revision 1.review1的意见很少 2.review2给了整整3页意见，特别细致（意见也比较针对） 修改了近一个月，再次提交： 2024-02-29 Awaiting Admin Processing 2024-03-02 Revision 2024-03-05 Awaiting Reviewer Invitation 2024-04-03 Returned by Admin 由于修改后忘了标记稿件修改的内容，白等了一个月，被编辑退回来了（期间发了邮件咨询为啥一直没动静） 2024-04-09 Awaiting Admin Processing 2024-04-10 Awaiting Reviewer Invitation 2024-04-12 Awaiting Reviewer Scores 2024-04-14 Awaiting AE Recommendation 2024-04-18 Awaiting Decision 2024-04-18 Major Revision 还是之前的审稿人： 1.review1基本没有意见 2.review2回复一审有2个意见没有修改满意 全部意见修改好，再次提交稿件，很快就中了： 2024-05-04 Awaiting Admin Processing 2024-05-06 Revision 2024-05-07 Awaiting Reviewer Selection 2024-05-08 Awaiting AE Recommendation 2024-05-08 Awaiting Decision 2024-05-08 Accept (Awaiting Production Checklist), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Thu May 09 08:46:21 CST 2024, time=2024-05-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2203572, encodeId=31f622035e234, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：23.06.30 submit 2024.1.17 major revision 2024.4.5 minor revision 2024.5.8 accept 没以前好中了，审稿也比之前慢了很多，投了将近一年才接收，中间催了好几次，但感觉作用不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a8588011, createdName=ms4000000276684931, createdTime=Thu May 09 00:41:20 CST 2024, time=2024-05-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2203430, encodeId=11eb22034308c, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：电子;健康 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ca8320823, createdName=ms9000001836297684, createdTime=Wed May 08 11:05:27 CST 2024, time=2024-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198712, encodeId=25f82198e124e, content=审稿速度:24.0 经验分享：审稿好慢。。。找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1076466407, createdName=ms9000001994529014, createdTime=Tue Apr 16 00:20:03 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196447, encodeId=57ee219644e77, content=偏重的研究方向：移动健康 经验分享：第一次投稿很快不到1月出结果：2024-1-31 Major Revision。2024-02-29 修改提交后显示 Awaiting Admin Processing，2024-03-02 Revision，2024-03-05 Awaiting Reviewer Invitation。然后就没消息了，不知道为啥返修后一直邀请审稿人。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Mon Apr 01 14:24:48 CST 2024, time=2024-04-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194973, encodeId=62d421949e3d2, content=我是这本期刊的审稿人，半年内已邀请审稿5次，主要方向为移动健康，信不信由你们。 如果有什么需要咨询的可留言或私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c1f6417428, createdName=ms2000001410436675, createdTime=Sun Mar 24 10:59:35 CST 2024, time=2024-03-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2184823, encodeId=a1ab2184823dd, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：2023年6月底投稿 2024年1月底接收编辑和审稿人都很温柔祝大家顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be958186362, createdName=论文保安, createdTime=Tue Jan 30 13:57:22 CST 2024, time=2024-01-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184988, encodeId=a0df21849883d, content=11月21号投稿，12月份大修，修回后1月25号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Jan 31 09:09:55 CST 2024, time=2024-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184884, encodeId=fb962184884a3, content=偏重的研究方向：移动健康 经验分享：1月6号投稿：Awaiting Admin Processing。1月7号：Submitted。1.14 Awaiting Reviewer Selection. 1.26 Awaiting Reviewer Scores 1.29 Awaiting AE Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Tue Jan 30 19:49:10 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省)]

2024-05-08 ms9000001836297684 来自湖南省

审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向：电子;健康
经验分享：无

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2184948, encodeId=f4f92184948cf, content=审稿速度:1.0 | 影响因子:3.9 偏重的研究方向：移动健康 经验分享：23.09.23 Awaiting Admin Processing 09.25 Awaiting AE Assignment 09.27 Awaiting Reviewers Selection 09.28 Awaiting Reviewers Assignment 10.9 Awaiting Reviewers Selection 10.11 Awaiting Reviewers Invitation 10.11 Awaiting Reviewers Assignment 10.12 Awaiting Reviewer Scores 10.25 Awaiting AE Recommendation 10.30 Awaiting Decision 11.7 Major Revision 11.19 修回 11.19 Awaiting Admin Processing 11.20 Awaiting Reviewers Selection 11.21 Awaiting Reviewers Assignment 11.22 Awaiting Reviewer Scores 11.27 Awaiting AE Recommendation 11.30 Awaiting Decision 11.30 Major Revision 12.29 修回 12.29 Awaiting Admin Processing 12.30 Revision 24.01.12 Awaiting Reviewer Scores 01.26 Awaiting AE Recommendation 01.30 Awaiting Decision 01.30 Accept（Awaiting Production Checklist） Digital Health 投稿分享 1. 投稿后编辑处理迅速，4天后稿件送外审； 2. 该杂志审稿人比较难邀请，一审经历了两轮邀请后有两位审稿人审稿，审稿迅速共持续13天，可能由于涉及多学科，一审后的Awaiting AE Recommendation和Awaiting Decision一共持续了13天； 3. 12天后返修二审，二审较快持续5天，Awaiting AE Recommendation和Awaiting Decision也较快且编辑当天给出意见，又给了大修； 4. 因为个人原因，一直拖到1个月返修期限12.29才返修，可能正好赶上编辑部放假，一直显示Revision状态，直到13天后直接跳到审稿人审稿状态，然后又经历了13天审稿，接着4天后直接接收（It is a pleasure to accept your manuscript entitled "XXX" in its current form for publication in Digital Health.）。 5. 一审中审稿人2给了9个意见，非常详细，对文章修改和文章写作很有帮助。二审中审稿人1没有任何意见，审稿人2还有少许意见，一直强调我的研究还有缺点，意见比较刁钻，所以编辑又给了大修。第一次和第二次修回查阅了大量文献且每次回复都两三千字，三审中审稿人2终于表示满意。此外，杂志编辑也是很友好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Tue Jan 30 23:24:46 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203595, encodeId=8e2022035955a, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：移动健康 经验分享：2024.1月6号投稿：Awaiting Admin Processing 2024.1月7号：Submitted 2024.1.14 Awaiting Reviewer Selection 2024.1.26 Awaiting Reviewer Scores 2024.1.29 Awaiting AE Recommendation 2024.1.30 Awaiting Decision 2024.1.31 Major Revision 1.review1的意见很少 2.review2给了整整3页意见，特别细致（意见也比较针对） 修改了近一个月，再次提交： 2024-02-29 Awaiting Admin Processing 2024-03-02 Revision 2024-03-05 Awaiting Reviewer Invitation 2024-04-03 Returned by Admin 由于修改后忘了标记稿件修改的内容，白等了一个月，被编辑退回来了（期间发了邮件咨询为啥一直没动静） 2024-04-09 Awaiting Admin Processing 2024-04-10 Awaiting Reviewer Invitation 2024-04-12 Awaiting Reviewer Scores 2024-04-14 Awaiting AE Recommendation 2024-04-18 Awaiting Decision 2024-04-18 Major Revision 还是之前的审稿人： 1.review1基本没有意见 2.review2回复一审有2个意见没有修改满意 全部意见修改好，再次提交稿件，很快就中了： 2024-05-04 Awaiting Admin Processing 2024-05-06 Revision 2024-05-07 Awaiting Reviewer Selection 2024-05-08 Awaiting AE Recommendation 2024-05-08 Awaiting Decision 2024-05-08 Accept (Awaiting Production Checklist), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Thu May 09 08:46:21 CST 2024, time=2024-05-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2203572, encodeId=31f622035e234, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：23.06.30 submit 2024.1.17 major revision 2024.4.5 minor revision 2024.5.8 accept 没以前好中了，审稿也比之前慢了很多，投了将近一年才接收，中间催了好几次，但感觉作用不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a8588011, createdName=ms4000000276684931, createdTime=Thu May 09 00:41:20 CST 2024, time=2024-05-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2203430, encodeId=11eb22034308c, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：电子;健康 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ca8320823, createdName=ms9000001836297684, createdTime=Wed May 08 11:05:27 CST 2024, time=2024-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198712, encodeId=25f82198e124e, content=审稿速度:24.0 经验分享：审稿好慢。。。找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1076466407, createdName=ms9000001994529014, createdTime=Tue Apr 16 00:20:03 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196447, encodeId=57ee219644e77, content=偏重的研究方向：移动健康 经验分享：第一次投稿很快不到1月出结果：2024-1-31 Major Revision。2024-02-29 修改提交后显示 Awaiting Admin Processing，2024-03-02 Revision，2024-03-05 Awaiting Reviewer Invitation。然后就没消息了，不知道为啥返修后一直邀请审稿人。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Mon Apr 01 14:24:48 CST 2024, time=2024-04-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194973, encodeId=62d421949e3d2, content=我是这本期刊的审稿人，半年内已邀请审稿5次，主要方向为移动健康，信不信由你们。 如果有什么需要咨询的可留言或私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c1f6417428, createdName=ms2000001410436675, createdTime=Sun Mar 24 10:59:35 CST 2024, time=2024-03-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2184823, encodeId=a1ab2184823dd, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：2023年6月底投稿 2024年1月底接收编辑和审稿人都很温柔祝大家顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be958186362, createdName=论文保安, createdTime=Tue Jan 30 13:57:22 CST 2024, time=2024-01-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184988, encodeId=a0df21849883d, content=11月21号投稿，12月份大修，修回后1月25号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Jan 31 09:09:55 CST 2024, time=2024-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184884, encodeId=fb962184884a3, content=偏重的研究方向：移动健康 经验分享：1月6号投稿：Awaiting Admin Processing。1月7号：Submitted。1.14 Awaiting Reviewer Selection. 1.26 Awaiting Reviewer Scores 1.29 Awaiting AE Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Tue Jan 30 19:49:10 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省)]

2024-04-16 ms9000001994529014 来自上海

审稿速度:24.0
经验分享：审稿好慢。。。找不到审稿人

29 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2184948, encodeId=f4f92184948cf, content=审稿速度:1.0 | 影响因子:3.9 偏重的研究方向：移动健康 经验分享：23.09.23 Awaiting Admin Processing 09.25 Awaiting AE Assignment 09.27 Awaiting Reviewers Selection 09.28 Awaiting Reviewers Assignment 10.9 Awaiting Reviewers Selection 10.11 Awaiting Reviewers Invitation 10.11 Awaiting Reviewers Assignment 10.12 Awaiting Reviewer Scores 10.25 Awaiting AE Recommendation 10.30 Awaiting Decision 11.7 Major Revision 11.19 修回 11.19 Awaiting Admin Processing 11.20 Awaiting Reviewers Selection 11.21 Awaiting Reviewers Assignment 11.22 Awaiting Reviewer Scores 11.27 Awaiting AE Recommendation 11.30 Awaiting Decision 11.30 Major Revision 12.29 修回 12.29 Awaiting Admin Processing 12.30 Revision 24.01.12 Awaiting Reviewer Scores 01.26 Awaiting AE Recommendation 01.30 Awaiting Decision 01.30 Accept（Awaiting Production Checklist） Digital Health 投稿分享 1. 投稿后编辑处理迅速，4天后稿件送外审； 2. 该杂志审稿人比较难邀请，一审经历了两轮邀请后有两位审稿人审稿，审稿迅速共持续13天，可能由于涉及多学科，一审后的Awaiting AE Recommendation和Awaiting Decision一共持续了13天； 3. 12天后返修二审，二审较快持续5天，Awaiting AE Recommendation和Awaiting Decision也较快且编辑当天给出意见，又给了大修； 4. 因为个人原因，一直拖到1个月返修期限12.29才返修，可能正好赶上编辑部放假，一直显示Revision状态，直到13天后直接跳到审稿人审稿状态，然后又经历了13天审稿，接着4天后直接接收（It is a pleasure to accept your manuscript entitled "XXX" in its current form for publication in Digital Health.）。 5. 一审中审稿人2给了9个意见，非常详细，对文章修改和文章写作很有帮助。二审中审稿人1没有任何意见，审稿人2还有少许意见，一直强调我的研究还有缺点，意见比较刁钻，所以编辑又给了大修。第一次和第二次修回查阅了大量文献且每次回复都两三千字，三审中审稿人2终于表示满意。此外，杂志编辑也是很友好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Tue Jan 30 23:24:46 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203595, encodeId=8e2022035955a, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：移动健康 经验分享：2024.1月6号投稿：Awaiting Admin Processing 2024.1月7号：Submitted 2024.1.14 Awaiting Reviewer Selection 2024.1.26 Awaiting Reviewer Scores 2024.1.29 Awaiting AE Recommendation 2024.1.30 Awaiting Decision 2024.1.31 Major Revision 1.review1的意见很少 2.review2给了整整3页意见，特别细致（意见也比较针对） 修改了近一个月，再次提交： 2024-02-29 Awaiting Admin Processing 2024-03-02 Revision 2024-03-05 Awaiting Reviewer Invitation 2024-04-03 Returned by Admin 由于修改后忘了标记稿件修改的内容，白等了一个月，被编辑退回来了（期间发了邮件咨询为啥一直没动静） 2024-04-09 Awaiting Admin Processing 2024-04-10 Awaiting Reviewer Invitation 2024-04-12 Awaiting Reviewer Scores 2024-04-14 Awaiting AE Recommendation 2024-04-18 Awaiting Decision 2024-04-18 Major Revision 还是之前的审稿人： 1.review1基本没有意见 2.review2回复一审有2个意见没有修改满意 全部意见修改好，再次提交稿件，很快就中了： 2024-05-04 Awaiting Admin Processing 2024-05-06 Revision 2024-05-07 Awaiting Reviewer Selection 2024-05-08 Awaiting AE Recommendation 2024-05-08 Awaiting Decision 2024-05-08 Accept (Awaiting Production Checklist), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Thu May 09 08:46:21 CST 2024, time=2024-05-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2203572, encodeId=31f622035e234, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：23.06.30 submit 2024.1.17 major revision 2024.4.5 minor revision 2024.5.8 accept 没以前好中了，审稿也比之前慢了很多，投了将近一年才接收，中间催了好几次，但感觉作用不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a8588011, createdName=ms4000000276684931, createdTime=Thu May 09 00:41:20 CST 2024, time=2024-05-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2203430, encodeId=11eb22034308c, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：电子;健康 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ca8320823, createdName=ms9000001836297684, createdTime=Wed May 08 11:05:27 CST 2024, time=2024-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198712, encodeId=25f82198e124e, content=审稿速度:24.0 经验分享：审稿好慢。。。找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1076466407, createdName=ms9000001994529014, createdTime=Tue Apr 16 00:20:03 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196447, encodeId=57ee219644e77, content=偏重的研究方向：移动健康 经验分享：第一次投稿很快不到1月出结果：2024-1-31 Major Revision。2024-02-29 修改提交后显示 Awaiting Admin Processing，2024-03-02 Revision，2024-03-05 Awaiting Reviewer Invitation。然后就没消息了，不知道为啥返修后一直邀请审稿人。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Mon Apr 01 14:24:48 CST 2024, time=2024-04-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194973, encodeId=62d421949e3d2, content=我是这本期刊的审稿人，半年内已邀请审稿5次，主要方向为移动健康，信不信由你们。 如果有什么需要咨询的可留言或私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c1f6417428, createdName=ms2000001410436675, createdTime=Sun Mar 24 10:59:35 CST 2024, time=2024-03-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2184823, encodeId=a1ab2184823dd, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：2023年6月底投稿 2024年1月底接收编辑和审稿人都很温柔祝大家顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be958186362, createdName=论文保安, createdTime=Tue Jan 30 13:57:22 CST 2024, time=2024-01-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184988, encodeId=a0df21849883d, content=11月21号投稿，12月份大修，修回后1月25号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Jan 31 09:09:55 CST 2024, time=2024-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184884, encodeId=fb962184884a3, content=偏重的研究方向：移动健康 经验分享：1月6号投稿：Awaiting Admin Processing。1月7号：Submitted。1.14 Awaiting Reviewer Selection. 1.26 Awaiting Reviewer Scores 1.29 Awaiting AE Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Tue Jan 30 19:49:10 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省)]

2024-04-01 ms3000001573572167 来自辽宁省

偏重的研究方向：移动健康
经验分享：第一次投稿很快不到1月出结果：2024-1-31 Major Revision。2024-02-29 修改提交后显示 Awaiting Admin Processing，2024-03-02 Revision，2024-03-05 Awaiting Reviewer Invitation。然后就没消息了，不知道为啥返修后一直邀请审稿人。。。。。

34 0

[GetPortalCommentsPageByObjectIdResponse(id=2184948, encodeId=f4f92184948cf, content=审稿速度:1.0 | 影响因子:3.9 偏重的研究方向：移动健康 经验分享：23.09.23 Awaiting Admin Processing 09.25 Awaiting AE Assignment 09.27 Awaiting Reviewers Selection 09.28 Awaiting Reviewers Assignment 10.9 Awaiting Reviewers Selection 10.11 Awaiting Reviewers Invitation 10.11 Awaiting Reviewers Assignment 10.12 Awaiting Reviewer Scores 10.25 Awaiting AE Recommendation 10.30 Awaiting Decision 11.7 Major Revision 11.19 修回 11.19 Awaiting Admin Processing 11.20 Awaiting Reviewers Selection 11.21 Awaiting Reviewers Assignment 11.22 Awaiting Reviewer Scores 11.27 Awaiting AE Recommendation 11.30 Awaiting Decision 11.30 Major Revision 12.29 修回 12.29 Awaiting Admin Processing 12.30 Revision 24.01.12 Awaiting Reviewer Scores 01.26 Awaiting AE Recommendation 01.30 Awaiting Decision 01.30 Accept（Awaiting Production Checklist） Digital Health 投稿分享 1. 投稿后编辑处理迅速，4天后稿件送外审； 2. 该杂志审稿人比较难邀请，一审经历了两轮邀请后有两位审稿人审稿，审稿迅速共持续13天，可能由于涉及多学科，一审后的Awaiting AE Recommendation和Awaiting Decision一共持续了13天； 3. 12天后返修二审，二审较快持续5天，Awaiting AE Recommendation和Awaiting Decision也较快且编辑当天给出意见，又给了大修； 4. 因为个人原因，一直拖到1个月返修期限12.29才返修，可能正好赶上编辑部放假，一直显示Revision状态，直到13天后直接跳到审稿人审稿状态，然后又经历了13天审稿，接着4天后直接接收（It is a pleasure to accept your manuscript entitled "XXX" in its current form for publication in Digital Health.）。 5. 一审中审稿人2给了9个意见，非常详细，对文章修改和文章写作很有帮助。二审中审稿人1没有任何意见，审稿人2还有少许意见，一直强调我的研究还有缺点，意见比较刁钻，所以编辑又给了大修。第一次和第二次修回查阅了大量文献且每次回复都两三千字，三审中审稿人2终于表示满意。此外，杂志编辑也是很友好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Tue Jan 30 23:24:46 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203595, encodeId=8e2022035955a, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：移动健康 经验分享：2024.1月6号投稿：Awaiting Admin Processing 2024.1月7号：Submitted 2024.1.14 Awaiting Reviewer Selection 2024.1.26 Awaiting Reviewer Scores 2024.1.29 Awaiting AE Recommendation 2024.1.30 Awaiting Decision 2024.1.31 Major Revision 1.review1的意见很少 2.review2给了整整3页意见，特别细致（意见也比较针对） 修改了近一个月，再次提交： 2024-02-29 Awaiting Admin Processing 2024-03-02 Revision 2024-03-05 Awaiting Reviewer Invitation 2024-04-03 Returned by Admin 由于修改后忘了标记稿件修改的内容，白等了一个月，被编辑退回来了（期间发了邮件咨询为啥一直没动静） 2024-04-09 Awaiting Admin Processing 2024-04-10 Awaiting Reviewer Invitation 2024-04-12 Awaiting Reviewer Scores 2024-04-14 Awaiting AE Recommendation 2024-04-18 Awaiting Decision 2024-04-18 Major Revision 还是之前的审稿人： 1.review1基本没有意见 2.review2回复一审有2个意见没有修改满意 全部意见修改好，再次提交稿件，很快就中了： 2024-05-04 Awaiting Admin Processing 2024-05-06 Revision 2024-05-07 Awaiting Reviewer Selection 2024-05-08 Awaiting AE Recommendation 2024-05-08 Awaiting Decision 2024-05-08 Accept (Awaiting Production Checklist), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Thu May 09 08:46:21 CST 2024, time=2024-05-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2203572, encodeId=31f622035e234, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：23.06.30 submit 2024.1.17 major revision 2024.4.5 minor revision 2024.5.8 accept 没以前好中了，审稿也比之前慢了很多，投了将近一年才接收，中间催了好几次，但感觉作用不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a8588011, createdName=ms4000000276684931, createdTime=Thu May 09 00:41:20 CST 2024, time=2024-05-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2203430, encodeId=11eb22034308c, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：电子;健康 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ca8320823, createdName=ms9000001836297684, createdTime=Wed May 08 11:05:27 CST 2024, time=2024-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198712, encodeId=25f82198e124e, content=审稿速度:24.0 经验分享：审稿好慢。。。找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1076466407, createdName=ms9000001994529014, createdTime=Tue Apr 16 00:20:03 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196447, encodeId=57ee219644e77, content=偏重的研究方向：移动健康 经验分享：第一次投稿很快不到1月出结果：2024-1-31 Major Revision。2024-02-29 修改提交后显示 Awaiting Admin Processing，2024-03-02 Revision，2024-03-05 Awaiting Reviewer Invitation。然后就没消息了，不知道为啥返修后一直邀请审稿人。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Mon Apr 01 14:24:48 CST 2024, time=2024-04-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194973, encodeId=62d421949e3d2, content=我是这本期刊的审稿人，半年内已邀请审稿5次，主要方向为移动健康，信不信由你们。 如果有什么需要咨询的可留言或私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c1f6417428, createdName=ms2000001410436675, createdTime=Sun Mar 24 10:59:35 CST 2024, time=2024-03-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2184823, encodeId=a1ab2184823dd, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：2023年6月底投稿 2024年1月底接收编辑和审稿人都很温柔祝大家顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be958186362, createdName=论文保安, createdTime=Tue Jan 30 13:57:22 CST 2024, time=2024-01-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184988, encodeId=a0df21849883d, content=11月21号投稿，12月份大修，修回后1月25号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Jan 31 09:09:55 CST 2024, time=2024-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184884, encodeId=fb962184884a3, content=偏重的研究方向：移动健康 经验分享：1月6号投稿：Awaiting Admin Processing。1月7号：Submitted。1.14 Awaiting Reviewer Selection. 1.26 Awaiting Reviewer Scores 1.29 Awaiting AE Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Tue Jan 30 19:49:10 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省)]

2024-03-24 ms2000001410436675 来自辽宁省

我是这本期刊的审稿人，半年内已邀请审稿5次，主要方向为移动健康，信不信由你们。
如果有什么需要咨询的可留言或私信我

14 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2184948, encodeId=f4f92184948cf, content=审稿速度:1.0 | 影响因子:3.9 偏重的研究方向：移动健康 经验分享：23.09.23 Awaiting Admin Processing 09.25 Awaiting AE Assignment 09.27 Awaiting Reviewers Selection 09.28 Awaiting Reviewers Assignment 10.9 Awaiting Reviewers Selection 10.11 Awaiting Reviewers Invitation 10.11 Awaiting Reviewers Assignment 10.12 Awaiting Reviewer Scores 10.25 Awaiting AE Recommendation 10.30 Awaiting Decision 11.7 Major Revision 11.19 修回 11.19 Awaiting Admin Processing 11.20 Awaiting Reviewers Selection 11.21 Awaiting Reviewers Assignment 11.22 Awaiting Reviewer Scores 11.27 Awaiting AE Recommendation 11.30 Awaiting Decision 11.30 Major Revision 12.29 修回 12.29 Awaiting Admin Processing 12.30 Revision 24.01.12 Awaiting Reviewer Scores 01.26 Awaiting AE Recommendation 01.30 Awaiting Decision 01.30 Accept（Awaiting Production Checklist） Digital Health 投稿分享 1. 投稿后编辑处理迅速，4天后稿件送外审； 2. 该杂志审稿人比较难邀请，一审经历了两轮邀请后有两位审稿人审稿，审稿迅速共持续13天，可能由于涉及多学科，一审后的Awaiting AE Recommendation和Awaiting Decision一共持续了13天； 3. 12天后返修二审，二审较快持续5天，Awaiting AE Recommendation和Awaiting Decision也较快且编辑当天给出意见，又给了大修； 4. 因为个人原因，一直拖到1个月返修期限12.29才返修，可能正好赶上编辑部放假，一直显示Revision状态，直到13天后直接跳到审稿人审稿状态，然后又经历了13天审稿，接着4天后直接接收（It is a pleasure to accept your manuscript entitled "XXX" in its current form for publication in Digital Health.）。 5. 一审中审稿人2给了9个意见，非常详细，对文章修改和文章写作很有帮助。二审中审稿人1没有任何意见，审稿人2还有少许意见，一直强调我的研究还有缺点，意见比较刁钻，所以编辑又给了大修。第一次和第二次修回查阅了大量文献且每次回复都两三千字，三审中审稿人2终于表示满意。此外，杂志编辑也是很友好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Tue Jan 30 23:24:46 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203595, encodeId=8e2022035955a, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：移动健康 经验分享：2024.1月6号投稿：Awaiting Admin Processing 2024.1月7号：Submitted 2024.1.14 Awaiting Reviewer Selection 2024.1.26 Awaiting Reviewer Scores 2024.1.29 Awaiting AE Recommendation 2024.1.30 Awaiting Decision 2024.1.31 Major Revision 1.review1的意见很少 2.review2给了整整3页意见，特别细致（意见也比较针对） 修改了近一个月，再次提交： 2024-02-29 Awaiting Admin Processing 2024-03-02 Revision 2024-03-05 Awaiting Reviewer Invitation 2024-04-03 Returned by Admin 由于修改后忘了标记稿件修改的内容，白等了一个月，被编辑退回来了（期间发了邮件咨询为啥一直没动静） 2024-04-09 Awaiting Admin Processing 2024-04-10 Awaiting Reviewer Invitation 2024-04-12 Awaiting Reviewer Scores 2024-04-14 Awaiting AE Recommendation 2024-04-18 Awaiting Decision 2024-04-18 Major Revision 还是之前的审稿人： 1.review1基本没有意见 2.review2回复一审有2个意见没有修改满意 全部意见修改好，再次提交稿件，很快就中了： 2024-05-04 Awaiting Admin Processing 2024-05-06 Revision 2024-05-07 Awaiting Reviewer Selection 2024-05-08 Awaiting AE Recommendation 2024-05-08 Awaiting Decision 2024-05-08 Accept (Awaiting Production Checklist), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Thu May 09 08:46:21 CST 2024, time=2024-05-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2203572, encodeId=31f622035e234, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：23.06.30 submit 2024.1.17 major revision 2024.4.5 minor revision 2024.5.8 accept 没以前好中了，审稿也比之前慢了很多，投了将近一年才接收，中间催了好几次，但感觉作用不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a8588011, createdName=ms4000000276684931, createdTime=Thu May 09 00:41:20 CST 2024, time=2024-05-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2203430, encodeId=11eb22034308c, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：电子;健康 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ca8320823, createdName=ms9000001836297684, createdTime=Wed May 08 11:05:27 CST 2024, time=2024-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198712, encodeId=25f82198e124e, content=审稿速度:24.0 经验分享：审稿好慢。。。找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1076466407, createdName=ms9000001994529014, createdTime=Tue Apr 16 00:20:03 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196447, encodeId=57ee219644e77, content=偏重的研究方向：移动健康 经验分享：第一次投稿很快不到1月出结果：2024-1-31 Major Revision。2024-02-29 修改提交后显示 Awaiting Admin Processing，2024-03-02 Revision，2024-03-05 Awaiting Reviewer Invitation。然后就没消息了，不知道为啥返修后一直邀请审稿人。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Mon Apr 01 14:24:48 CST 2024, time=2024-04-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194973, encodeId=62d421949e3d2, content=我是这本期刊的审稿人，半年内已邀请审稿5次，主要方向为移动健康，信不信由你们。 如果有什么需要咨询的可留言或私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c1f6417428, createdName=ms2000001410436675, createdTime=Sun Mar 24 10:59:35 CST 2024, time=2024-03-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2184823, encodeId=a1ab2184823dd, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：2023年6月底投稿 2024年1月底接收编辑和审稿人都很温柔祝大家顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be958186362, createdName=论文保安, createdTime=Tue Jan 30 13:57:22 CST 2024, time=2024-01-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184988, encodeId=a0df21849883d, content=11月21号投稿，12月份大修，修回后1月25号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Jan 31 09:09:55 CST 2024, time=2024-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184884, encodeId=fb962184884a3, content=偏重的研究方向：移动健康 经验分享：1月6号投稿：Awaiting Admin Processing。1月7号：Submitted。1.14 Awaiting Reviewer Selection. 1.26 Awaiting Reviewer Scores 1.29 Awaiting AE Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Tue Jan 30 19:49:10 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省)]

2024-01-30 论文保安来自河南省

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：移动健康
经验分享：2023年6月底投稿 2024年1月底接收编辑和审稿人都很温柔祝大家顺利！

20 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2184948, encodeId=f4f92184948cf, content=审稿速度:1.0 | 影响因子:3.9 偏重的研究方向：移动健康 经验分享：23.09.23 Awaiting Admin Processing 09.25 Awaiting AE Assignment 09.27 Awaiting Reviewers Selection 09.28 Awaiting Reviewers Assignment 10.9 Awaiting Reviewers Selection 10.11 Awaiting Reviewers Invitation 10.11 Awaiting Reviewers Assignment 10.12 Awaiting Reviewer Scores 10.25 Awaiting AE Recommendation 10.30 Awaiting Decision 11.7 Major Revision 11.19 修回 11.19 Awaiting Admin Processing 11.20 Awaiting Reviewers Selection 11.21 Awaiting Reviewers Assignment 11.22 Awaiting Reviewer Scores 11.27 Awaiting AE Recommendation 11.30 Awaiting Decision 11.30 Major Revision 12.29 修回 12.29 Awaiting Admin Processing 12.30 Revision 24.01.12 Awaiting Reviewer Scores 01.26 Awaiting AE Recommendation 01.30 Awaiting Decision 01.30 Accept（Awaiting Production Checklist） Digital Health 投稿分享 1. 投稿后编辑处理迅速，4天后稿件送外审； 2. 该杂志审稿人比较难邀请，一审经历了两轮邀请后有两位审稿人审稿，审稿迅速共持续13天，可能由于涉及多学科，一审后的Awaiting AE Recommendation和Awaiting Decision一共持续了13天； 3. 12天后返修二审，二审较快持续5天，Awaiting AE Recommendation和Awaiting Decision也较快且编辑当天给出意见，又给了大修； 4. 因为个人原因，一直拖到1个月返修期限12.29才返修，可能正好赶上编辑部放假，一直显示Revision状态，直到13天后直接跳到审稿人审稿状态，然后又经历了13天审稿，接着4天后直接接收（It is a pleasure to accept your manuscript entitled "XXX" in its current form for publication in Digital Health.）。 5. 一审中审稿人2给了9个意见，非常详细，对文章修改和文章写作很有帮助。二审中审稿人1没有任何意见，审稿人2还有少许意见，一直强调我的研究还有缺点，意见比较刁钻，所以编辑又给了大修。第一次和第二次修回查阅了大量文献且每次回复都两三千字，三审中审稿人2终于表示满意。此外，杂志编辑也是很友好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Tue Jan 30 23:24:46 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203595, encodeId=8e2022035955a, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：移动健康 经验分享：2024.1月6号投稿：Awaiting Admin Processing 2024.1月7号：Submitted 2024.1.14 Awaiting Reviewer Selection 2024.1.26 Awaiting Reviewer Scores 2024.1.29 Awaiting AE Recommendation 2024.1.30 Awaiting Decision 2024.1.31 Major Revision 1.review1的意见很少 2.review2给了整整3页意见，特别细致（意见也比较针对） 修改了近一个月，再次提交： 2024-02-29 Awaiting Admin Processing 2024-03-02 Revision 2024-03-05 Awaiting Reviewer Invitation 2024-04-03 Returned by Admin 由于修改后忘了标记稿件修改的内容，白等了一个月，被编辑退回来了（期间发了邮件咨询为啥一直没动静） 2024-04-09 Awaiting Admin Processing 2024-04-10 Awaiting Reviewer Invitation 2024-04-12 Awaiting Reviewer Scores 2024-04-14 Awaiting AE Recommendation 2024-04-18 Awaiting Decision 2024-04-18 Major Revision 还是之前的审稿人： 1.review1基本没有意见 2.review2回复一审有2个意见没有修改满意 全部意见修改好，再次提交稿件，很快就中了： 2024-05-04 Awaiting Admin Processing 2024-05-06 Revision 2024-05-07 Awaiting Reviewer Selection 2024-05-08 Awaiting AE Recommendation 2024-05-08 Awaiting Decision 2024-05-08 Accept (Awaiting Production Checklist), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Thu May 09 08:46:21 CST 2024, time=2024-05-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2203572, encodeId=31f622035e234, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：23.06.30 submit 2024.1.17 major revision 2024.4.5 minor revision 2024.5.8 accept 没以前好中了，审稿也比之前慢了很多，投了将近一年才接收，中间催了好几次，但感觉作用不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a8588011, createdName=ms4000000276684931, createdTime=Thu May 09 00:41:20 CST 2024, time=2024-05-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2203430, encodeId=11eb22034308c, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：电子;健康 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ca8320823, createdName=ms9000001836297684, createdTime=Wed May 08 11:05:27 CST 2024, time=2024-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198712, encodeId=25f82198e124e, content=审稿速度:24.0 经验分享：审稿好慢。。。找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1076466407, createdName=ms9000001994529014, createdTime=Tue Apr 16 00:20:03 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196447, encodeId=57ee219644e77, content=偏重的研究方向：移动健康 经验分享：第一次投稿很快不到1月出结果：2024-1-31 Major Revision。2024-02-29 修改提交后显示 Awaiting Admin Processing，2024-03-02 Revision，2024-03-05 Awaiting Reviewer Invitation。然后就没消息了，不知道为啥返修后一直邀请审稿人。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Mon Apr 01 14:24:48 CST 2024, time=2024-04-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194973, encodeId=62d421949e3d2, content=我是这本期刊的审稿人，半年内已邀请审稿5次，主要方向为移动健康，信不信由你们。 如果有什么需要咨询的可留言或私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c1f6417428, createdName=ms2000001410436675, createdTime=Sun Mar 24 10:59:35 CST 2024, time=2024-03-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2184823, encodeId=a1ab2184823dd, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：2023年6月底投稿 2024年1月底接收编辑和审稿人都很温柔祝大家顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be958186362, createdName=论文保安, createdTime=Tue Jan 30 13:57:22 CST 2024, time=2024-01-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184988, encodeId=a0df21849883d, content=11月21号投稿，12月份大修，修回后1月25号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Jan 31 09:09:55 CST 2024, time=2024-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184884, encodeId=fb962184884a3, content=偏重的研究方向：移动健康 经验分享：1月6号投稿：Awaiting Admin Processing。1月7号：Submitted。1.14 Awaiting Reviewer Selection. 1.26 Awaiting Reviewer Scores 1.29 Awaiting AE Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Tue Jan 30 19:49:10 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省)]

2024-01-31 ms5000000983971375 来自陕西省

11月21号投稿，12月份大修，修回后1月25号拒稿

23 0

[GetPortalCommentsPageByObjectIdResponse(id=2184948, encodeId=f4f92184948cf, content=审稿速度:1.0 | 影响因子:3.9 偏重的研究方向：移动健康 经验分享：23.09.23 Awaiting Admin Processing 09.25 Awaiting AE Assignment 09.27 Awaiting Reviewers Selection 09.28 Awaiting Reviewers Assignment 10.9 Awaiting Reviewers Selection 10.11 Awaiting Reviewers Invitation 10.11 Awaiting Reviewers Assignment 10.12 Awaiting Reviewer Scores 10.25 Awaiting AE Recommendation 10.30 Awaiting Decision 11.7 Major Revision 11.19 修回 11.19 Awaiting Admin Processing 11.20 Awaiting Reviewers Selection 11.21 Awaiting Reviewers Assignment 11.22 Awaiting Reviewer Scores 11.27 Awaiting AE Recommendation 11.30 Awaiting Decision 11.30 Major Revision 12.29 修回 12.29 Awaiting Admin Processing 12.30 Revision 24.01.12 Awaiting Reviewer Scores 01.26 Awaiting AE Recommendation 01.30 Awaiting Decision 01.30 Accept（Awaiting Production Checklist） Digital Health 投稿分享 1. 投稿后编辑处理迅速，4天后稿件送外审； 2. 该杂志审稿人比较难邀请，一审经历了两轮邀请后有两位审稿人审稿，审稿迅速共持续13天，可能由于涉及多学科，一审后的Awaiting AE Recommendation和Awaiting Decision一共持续了13天； 3. 12天后返修二审，二审较快持续5天，Awaiting AE Recommendation和Awaiting Decision也较快且编辑当天给出意见，又给了大修； 4. 因为个人原因，一直拖到1个月返修期限12.29才返修，可能正好赶上编辑部放假，一直显示Revision状态，直到13天后直接跳到审稿人审稿状态，然后又经历了13天审稿，接着4天后直接接收（It is a pleasure to accept your manuscript entitled "XXX" in its current form for publication in Digital Health.）。 5. 一审中审稿人2给了9个意见，非常详细，对文章修改和文章写作很有帮助。二审中审稿人1没有任何意见，审稿人2还有少许意见，一直强调我的研究还有缺点，意见比较刁钻，所以编辑又给了大修。第一次和第二次修回查阅了大量文献且每次回复都两三千字，三审中审稿人2终于表示满意。此外，杂志编辑也是很友好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Tue Jan 30 23:24:46 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203595, encodeId=8e2022035955a, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：移动健康 经验分享：2024.1月6号投稿：Awaiting Admin Processing 2024.1月7号：Submitted 2024.1.14 Awaiting Reviewer Selection 2024.1.26 Awaiting Reviewer Scores 2024.1.29 Awaiting AE Recommendation 2024.1.30 Awaiting Decision 2024.1.31 Major Revision 1.review1的意见很少 2.review2给了整整3页意见，特别细致（意见也比较针对） 修改了近一个月，再次提交： 2024-02-29 Awaiting Admin Processing 2024-03-02 Revision 2024-03-05 Awaiting Reviewer Invitation 2024-04-03 Returned by Admin 由于修改后忘了标记稿件修改的内容，白等了一个月，被编辑退回来了（期间发了邮件咨询为啥一直没动静） 2024-04-09 Awaiting Admin Processing 2024-04-10 Awaiting Reviewer Invitation 2024-04-12 Awaiting Reviewer Scores 2024-04-14 Awaiting AE Recommendation 2024-04-18 Awaiting Decision 2024-04-18 Major Revision 还是之前的审稿人： 1.review1基本没有意见 2.review2回复一审有2个意见没有修改满意 全部意见修改好，再次提交稿件，很快就中了： 2024-05-04 Awaiting Admin Processing 2024-05-06 Revision 2024-05-07 Awaiting Reviewer Selection 2024-05-08 Awaiting AE Recommendation 2024-05-08 Awaiting Decision 2024-05-08 Accept (Awaiting Production Checklist), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Thu May 09 08:46:21 CST 2024, time=2024-05-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2203572, encodeId=31f622035e234, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：23.06.30 submit 2024.1.17 major revision 2024.4.5 minor revision 2024.5.8 accept 没以前好中了，审稿也比之前慢了很多，投了将近一年才接收，中间催了好几次，但感觉作用不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a8588011, createdName=ms4000000276684931, createdTime=Thu May 09 00:41:20 CST 2024, time=2024-05-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2203430, encodeId=11eb22034308c, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：电子;健康 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ca8320823, createdName=ms9000001836297684, createdTime=Wed May 08 11:05:27 CST 2024, time=2024-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198712, encodeId=25f82198e124e, content=审稿速度:24.0 经验分享：审稿好慢。。。找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1076466407, createdName=ms9000001994529014, createdTime=Tue Apr 16 00:20:03 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196447, encodeId=57ee219644e77, content=偏重的研究方向：移动健康 经验分享：第一次投稿很快不到1月出结果：2024-1-31 Major Revision。2024-02-29 修改提交后显示 Awaiting Admin Processing，2024-03-02 Revision，2024-03-05 Awaiting Reviewer Invitation。然后就没消息了，不知道为啥返修后一直邀请审稿人。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Mon Apr 01 14:24:48 CST 2024, time=2024-04-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194973, encodeId=62d421949e3d2, content=我是这本期刊的审稿人，半年内已邀请审稿5次，主要方向为移动健康，信不信由你们。 如果有什么需要咨询的可留言或私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c1f6417428, createdName=ms2000001410436675, createdTime=Sun Mar 24 10:59:35 CST 2024, time=2024-03-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2184823, encodeId=a1ab2184823dd, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：移动健康 经验分享：2023年6月底投稿 2024年1月底接收编辑和审稿人都很温柔祝大家顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be958186362, createdName=论文保安, createdTime=Tue Jan 30 13:57:22 CST 2024, time=2024-01-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184988, encodeId=a0df21849883d, content=11月21号投稿，12月份大修，修回后1月25号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Jan 31 09:09:55 CST 2024, time=2024-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184884, encodeId=fb962184884a3, content=偏重的研究方向：移动健康 经验分享：1月6号投稿：Awaiting Admin Processing。1月7号：Submitted。1.14 Awaiting Reviewer Selection. 1.26 Awaiting Reviewer Scores 1.29 Awaiting AE Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc38419310, createdName=ms3000001573572167, createdTime=Tue Jan 30 19:49:10 CST 2024, time=2024-01-30, status=1, ipAttribution=江苏省)]

2024-01-30 ms3000001573572167 来自江苏省

偏重的研究方向：移动健康
经验分享：1月6号投稿：Awaiting Admin Processing。1月7号：Submitted。1.14 Awaiting Reviewer Selection. 1.26 Awaiting Reviewer Scores 1.29 Awaiting AE Recommendation

19 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务